Search research articles
Contact Us
Filters
Showing results (1-10 of 216) with videos related to
Page
of 22
Sort By:
Child Welfare
|
April 1, 1982
Toward humanizing adoption
C J Sorich, R Siebert
Seminars in Oncology
|
February 1, 1992
Intraperitoneal carboplatin: rationale and experience
J L Speyer, J Sorich
The Pharmacogenomics Journal
|
September 11, 2013
Interpreting the clinical utility of a pharmacogenomic marker based on observational association studies
M J Sorich, M Coory
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2022
Response to Mazzaschi and Buti
Ashley M Hopkins, Michael J Sorich
Current Drug Metabolism
|
May 18, 2012
Personalized medicine: potential, barriers and contemporary issues
Michael J Sorich, Ross A McKinnon
Clinical Pharmacology and Therapeutics
|
September 16, 2022
The Broader Context of Liquid Biopsy in Absorption, Distribution, Metabolism, and Elimination
Andrew Rowland, Zivile Useckaite, Michael J Sorich
BMC Medicine
|
September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
Ashley M Hopkins, Andrew Rowland, Michael J Sorich
Therapeutic Advances in Drug Safety
|
August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes
Michael J Sorich, Andrew Rowland, Michael D Wiese
Journal of Clinical Medicine
|
July 3, 2020
Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease
Lauren A Newman, Michael J Sorich, Andrew Rowland
JAMA Oncology
|
April 24, 2020
Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy-Reply
Ganessan Kichenadasse, Ashley M Hopkins, Michael J Sorich
Page
of 22
Search research articles
Search
Showing results (1-10 of 216) with videos related to
Sort By:
Page
of 22
Child Welfare
|
April 1, 1982
Toward humanizing adoption
C J Sorich, R Siebert
Seminars in Oncology
|
February 1, 1992
Intraperitoneal carboplatin: rationale and experience
J L Speyer, J Sorich
The Pharmacogenomics Journal
|
September 11, 2013
Interpreting the clinical utility of a pharmacogenomic marker based on observational association studies
M J Sorich, M Coory
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2022
Response to Mazzaschi and Buti
Ashley M Hopkins, Michael J Sorich
Current Drug Metabolism
|
May 18, 2012
Personalized medicine: potential, barriers and contemporary issues
Michael J Sorich, Ross A McKinnon
Clinical Pharmacology and Therapeutics
|
September 16, 2022
The Broader Context of Liquid Biopsy in Absorption, Distribution, Metabolism, and Elimination
Andrew Rowland, Zivile Useckaite, Michael J Sorich
BMC Medicine
|
September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
Ashley M Hopkins, Andrew Rowland, Michael J Sorich
Therapeutic Advances in Drug Safety
|
August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes
Michael J Sorich, Andrew Rowland, Michael D Wiese
Journal of Clinical Medicine
|
July 3, 2020
Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease
Lauren A Newman, Michael J Sorich, Andrew Rowland
JAMA Oncology
|
April 24, 2020
Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy-Reply
Ganessan Kichenadasse, Ashley M Hopkins, Michael J Sorich
Page
of 22